Eyenovia will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness in children after it failed to slow the condition's progression, sending its shares ...

(Reuters) -Eyenovia said on Friday it would terminate a late-stage study for its experimental drug-device combination to treat an eye disease after failing the main goal of slowing the progression of ...

The best eye creams that really work for all skin types and issues, including wrinkles, dryness, anti-aging, dark circles, ...

New data support a change in management of the common eye disease glaucoma from eye drops, the current standard of care, to a ...

Do you ever feel like your skin feels and looks tired? Over the years, our face, especially our under-eye areas, can tell on ...

Glaucoma occurs due to optic nerve damage. A common treatment is prescription eye drops. Although eye drops do not cure or reverse vision loss, they can help prevent optic nerve damage.

Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...

Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the brain, a key factor in dementias like Alzheimer's. This study, using zebrafish and mice models, s ...

In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has ...

your doctor will treat one eye at a time, with a few weeks in between. Usually you need just one treatment for each eye. Your doctor might try a laser along with anti-VEGF shots if the shots alone ...